NeuroBo Pharmaceuticals Inc (NRBO)

[dinogreeves]

Thank you Crude, here is a look at something of importance and the possibilities. Here is my reasoning, if you look at the 8K, they are indicating that this agreement supersedes the previous one, which could mean that they probably had a longer lease on the previous lease agreement and now they changed to one year agreement and this particular one supersedes the other on which was suppose to end in November 2021, they shortened the lease agreement. So I ask why would they do that if they had no plans to sell the company or get into bigger facility, I mean look at price tag on that space. I am thinking they will probably sell the company once that interim Phase data comes out and the Alzheimers pipeline data by mid year. Remember, as it stands right now, we are waiting on two catalyst, one is Interim Phase 3 data on Neuropathic Diabetic Pain, which is to be released before March 31st, and the second one is the previous GEMP pipeline that is to be released early 2020, so early 2020 again could be anything before March 31st, then we have the Alzheimers which we might get either by mid or 3 quarter of this year. If all those pipelines to well in the clinical trials, logic would tell me if the company shortened the lease agreement they would probably entertain the right offer and that way they are not tied into the lease, Ummm, I wonder if they are already in talks? It will be interesting to see how this unfolds with a small float like this one.


https://www.sec.gov/Archives/edgar/data/1638287/000155837020000476/f8-k.htm